See the latest news and media coverage for PhenoNet. We track all announcements, press releases, and industry mentions in real time, all in one place.
Clinical-stage biotechnology company developing precision neurodegenerative therapies
phenonet.usLast updated
Today, PhenoNet, Inc., an advanced clinical-stage biotechnology company developing therapies for neurodegenerative diseases, announced the completion of recruitment and randomization on August 27, ...
FDA clears PhenoNet Inc. to advance PHENOGENE-1A into Phase 3 trials for early Alzheimer's disease, including APOE4 and non-APOE4 patients.
Track PhenoNet and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.